[ DOMAIN ]
pharm114.or.kr
#386,833Top 38.7%▼ 761
Overview
30-day trend
Last 7 frozen daily snapshots. See rank history for full detail.
- First seen
- TLD
- .or.kr
- 24h change
- ▼ 761
- 7d change
- ▼ 761
- Score
- 2.00
- Snapshot
- 1970-01-01
Registered with , expires .
Technologies
No technologies detected on pharm114.or.kr yet.
Contacts
No emails or phone numbers found on pharm114.or.kr yet.
Rank history
7 daily snapshots tracked. Lower rank numbers indicate higher composite score.
Whois — pharm114.or.kr
- Registrar
- Created
- —
- Expires
Full whois record
query : pharm114.or.kr # KOREAN(UTF8) 도메인이름 : pharm114.or.kr 등록인 : (사)대한약사회 등록인 주소 : 서울특별시 서초구 효령로 194 대한약사회관 등록인 우편번호 : 06708 책임자 : (사)대한약사회 책임자 전자우편 : [email protected] 책임자 전화번호 : 8225811201 등록일 : 2007. 05. 30. 최근 정보 변경일 : 2024. 06. 28. 사용 종료일 : 2027. 05. 30. 정보공개여부 : Y 등록대행자 : 메가존(주)(http://HOSTING.KR) DNSSEC : 미서명 등록정보 보호 : clientTransferProhibited 1차 네임서버 정보 호스트이름 : ns1-1.ns-ncloud.com 2차 네임서버 정보 호스트이름 : ns1-2.ns-ncloud.com 네임서버 이름이 .kr이 아닌 경우는 IP주소가 보이지 않습니다. # ENGLISH Domain Name : pharm114.or.kr Registrant : The Korean Pharmaceutical Association Registrant Address : Seocho-guSeoul, 194Hyoryeong-ro, Registrant Zip Code : 06708 Administrative Contact(AC) : The Korean Pharmaceutical Association AC E-Mail : [email protected] AC Phone Number : 8225811201 Registered Date : 2007. 05. 30. Last Updated Date : 2024. 06. 28. Expiration Date : 2027. 05. 30. Publishes : Y Authorized Agency : Megazone(http://HOSTING.KR) DNSSEC : unsigned Domain Status : clientTransferProhibited Primary Name Server Host Name : ns1-1.ns-ncloud.com Secondary Name Server Host Name : ns1-2.ns-ncloud.com - KISA/KRNIC WHOIS Service -
Registration expiry lifecycle
Upcoming
- Expected expiry
- 2027-05-30
- Registrar
- —
- Next verification
- 2027-03-01
- Checks completed
- 0
This is the latest registration state. DNS is supporting evidence; only an explicit registry or WHOIS not-found response confirms expiration.
DNS records
Outbound links
No outbound links discovered for pharm114.or.kr yet.